论文部分内容阅读
6月22日下午,江苏省南京市鼓楼区人民法院对国内首例试药人直接状告试药方人身索赔案件进行宣判。法院认定,被告医院及药厂的试药行为,没有构成对原告的身体伤害,但被告医院的试药过程中侵犯了原告郭朝斌的知情权,判令赔偿其精神抚慰金1万元,被告药厂对此赔偿承担连带责任。尽管只判赔1万元,但此案具有里程碑意义。至少,它为目前中国每年直接参与试药的50多万名“从业人员”提供了维权的方向。
On the afternoon of June 22, the People’s Court of Nanjing City, Jiangsu Province, Drum Tower District, sentenced the first trial drugmaker to sue the party for personal claims directly. The court held that the trial of the defendant hospitals and pharmaceutical companies did not constitute a physical injury to the plaintiffs. However, the defendant’s hospital violated the plaintiff’s right to be informed of the right to information during the trial of the drug and ordered the court to compensate for his mental retardation amount of 10,000 yuan. Factory compensation for this joint liability. Although only 10 million compensation, but the case a landmark. At the very least, it provides the direction of human rights protection to more than 500,000 “practitioners” who are currently directly involved in the trial in China.